RESEARCH TRIANGLE PARK, N.C., Dec. 7 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OTC:ICOR.OB) (BULLETIN BOARD: ICOR.OB) today announced that Institutional Shareholder Services...
Losses Continue to Narrow as Company Focuses on Healthcare RESEARCH TRIANGLE PARK, N.C., Nov. 14 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OTC:ICOR.OB) (BULLETIN BOARD:...
NIAAA to fund continued research in detection of alcohol-related diseases RESEARCH TRIANGLE PARK, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OTC:ICOR.OB...
Allowed patent covers measurement of several tissue structure features for high-throughput screening RESEARCH TRIANGLE PARK, N.C., Sept. 29 /PRNewswire-FirstCall/ -- Biotechnology company...
Acquisition Brings Metabolomics and Biomarker Expertise to Clinical Data NEWTON, Mass. and RESEARCH TRIANGLE PARK, N.C., Sept. 20 /PRNewswire- FirstCall/ -- Clinical Data, Inc. (NASDAQ:CLDA) and...
RESEARCH TRIANGLE PARK, N.C., Sept. 8 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OTC:ICOR.OB) (BULLETIN BOARD: ICOR.OB) today announced that its gene expression profiling...
RESEARCH TRIANGLE PARK, N.C., Aug. 29 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OCT Bulletin Board: ICOR.OB) today announced that it has received a $1.2 million Phase II...
RESEARCH TRIANGLE PARK, N.C., Aug. 23 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc. (OCTBB: ICOR.OB) today announced that it has signed an agreement with Isis Pharmaceuticals to...
Healthcare Revenue Increases 11% in Quarter, First Half Loss Narrows on Asset Sale RESEARCH TRIANGLE PARK, N.C., Aug. 15 /PRNewswire-FirstCall/ -- Biotechnology company Icoria, Inc...
RESEARCH TRIANGLE PARK, N.C., Aug. 8 /PRNewswire-FirstCall/ -- Icoria, Inc. (OTCBB: ICOR.OB), announced today that on Monday, August 15 it will report its 2005 second quarter financial results...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.